SwePub
Sök i LIBRIS databas

  Extended search

L773:0889 1591 OR L773:1090 2139 OR L773:2666 3546
 

Search: L773:0889 1591 OR L773:1090 2139 OR L773:2666 3546 > A role for inflamma...

  • Bay-Richter, CecilieLund University,Lunds universitet,Psykiatri, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Psychiatry (Lund),Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Aarhus University, Denmark (author)

A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • ACADEMIC PRESS INC ELSEVIER SCIENCE,2015
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-121771
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-121771URI
  • https://doi.org/10.1016/j.bbi.2014.07.012DOI
  • https://lup.lub.lu.se/record/4614563URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:131952759URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Michigan State University; Van Andel Research Institute; Swedish Research Council [2009-4284, 2011-4787, 2002-5297, 2008-2922, 2009-7052, 2013-2838]; Province of Scania clinical state grants (ALF); Australian Research Council; National Health and Medical Research Council, Australia
  • Background: Patients with depression and suicidality suffer from low-grade neuroinflammation. Proinflammatory cytokines activate indoleamine 2,3-dioxygenase, an initial enzyme of the kynurenine pathway. This pathway produces neuroactive metabolites, including quinolinic- and kynurenic acid, binding to the glutamate N-methyl-D-aspartate-receptor, which is hypothesized to be part of the neural mechanisms underlying symptoms of depression. We therefore hypothesized that symptoms of depression and suicidality would fluctuate over time in patients prone to suicidal behavior, depending on the degree of inflammation and kynurenine metabolite levels in the cerebrospinal fluid (CSF). Methods: We measured cytokines and kynurenine metabolites in CSF, collected from suicide attempters at repeated occasions over 2 years (total patient samples n = 143, individuals n = 30) and healthy controls (n = 36). The association between the markers and psychiatric symptoms was assessed using the Montgomery Asberg Depression Rating Scale and the Suicide Assessment Scale. Results: Quinolinic acid was increased and kynurenic acid decreased over time in suicidal patients versus healthy controls. Furthermore, we found a significant association between low kynurenic acid and severe depressive symptoms, as well as between high interleukin-6 levels and more severe suicidal symptoms. Conclusions: We demonstrate a long-term dysregulation of the kynurenine pathway in the central nervous system of suicide attempters. An increased load of inflammatory cytokines was coupled to more severe symptoms. We therefore suggest that patients with a dysregulated kynurenine pathway are vulnerable to develop depressive symptoms upon inflammatory conditions, as a result the excess production of the NMDA-receptor agonist quinolinic acid. This study provides a neurobiological framework supporting the use of NMDA-receptor antagonists in the treatment of suicidality and depression. (C) 2014 Elsevier Inc. All rights reserved.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Linderholm, Klas R.Karolinska Institute, Sweden (author)
  • Lim, Chai K.Macquarie University, Australia (author)
  • Samuelsson, MartinLinköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Psykiatriska kliniken(Swepub:liu)marsa78 (author)
  • Träskman Bendz, LilLund University,Lunds universitet,Psykiatri, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Psychiatry (Lund),Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden(Swepub:lu)psyk-lt8 (author)
  • Guillemin, Gilles J.Macquarie University, Australia (author)
  • Erhardt, SophieKarolinska Institutet,Karolinska Institute, Sweden (author)
  • Brundin, LenaLund University,Lunds universitet,Psykiatri, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Psychiatry (Lund),Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Michigan State University, MI USA; Van Andel Research Institute, MI USA(Swepub:lu)mphy-lla (author)
  • Psykiatri, LundSektion IV (creator_code:org_t)

Related titles

  • In:Brain, behavior, and immunity: ACADEMIC PRESS INC ELSEVIER SCIENCE43, s. 110-1170889-15911090-2139

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view